Pharmacodynamics Study to Investigate the Effect of Evogliptin on Bone Metabolism in Healthy Volunteers
Phase of Trial: Phase IV
Latest Information Update: 27 Jul 2016
At a glance
- Drugs Evogliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 21 Jul 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Nov 2016.
- 21 Jul 2016 Status changed from not yet recruiting to recruiting.
- 29 Oct 2015 New trial record